- G20 -

is possible Bringing hope and potential help to nanorare patients For free for life Creating a betterfuture for nanorare Our mission is to apply the efficiency versatility and specificity of antisense technology to charitably provide experimental antisense oligonucleotide ASO medicines to treat patients with nanorare diseases. Choose your pathway Physicians Patients Institutions Who we treat Are you nanorare. Nanorare describes a patient that because of their unique gene mutation will be only 1 to 30 patients worldwide with that exact mutation. Most nanorare patients have a single gene mutation that causes a cluster of symptoms that can affect their health.